The present invention relates to antibody molecules, in particular antibody molecules that bind Transforming Growth Factor beta (TGF.beta.), and uses thereof. More particularly, the invention relates to antibody molecules that bind and preferably neutralize TGF.beta.1, TGF.beta.2 and TGF.beta.3, so-called "pan-specific" antibody molecules, and uses of such antibody molecules. Preferred embodiments within the present invention are antibody molecules, whether whole antibody (e.g. IgG, such as IgG1 or IgG4) or antibody fragments (e.g. scFv, Fab, dAb).

 
Web www.patentalert.com

< Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith

< Extracellular matrix binding chimeric proteins and methods of use thereof

> Monoclonal antibodies to secreted and transmembrane polypeptides

> Method for removal of water associated with bone while diminishing the dimensional changes associated with lyophilization
~ 00611